Grandview Asset Management LLC Grows Stake in Versum Materials Inc (VSM)

Share on StockTwits

Grandview Asset Management LLC raised its holdings in shares of Versum Materials Inc (NYSE:VSM) by 8.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,013 shares of the basic materials company’s stock after buying an additional 657 shares during the quarter. Grandview Asset Management LLC’s holdings in Versum Materials were worth $403,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc lifted its holdings in shares of Versum Materials by 3.9% during the third quarter. Vanguard Group Inc now owns 10,282,274 shares of the basic materials company’s stock worth $370,264,000 after purchasing an additional 385,271 shares during the period. Boston Partners boosted its stake in Versum Materials by 14.1% during the 4th quarter. Boston Partners now owns 5,764,801 shares of the basic materials company’s stock valued at $159,800,000 after purchasing an additional 710,352 shares during the period. Gates Capital Management Inc. boosted its stake in Versum Materials by 3.6% during the 4th quarter. Gates Capital Management Inc. now owns 2,427,530 shares of the basic materials company’s stock valued at $67,291,000 after purchasing an additional 83,721 shares during the period. Shapiro Capital Management LLC boosted its stake in Versum Materials by 1.2% during the 4th quarter. Shapiro Capital Management LLC now owns 2,328,448 shares of the basic materials company’s stock valued at $64,545,000 after purchasing an additional 27,180 shares during the period. Finally, D. E. Shaw & Co. Inc. boosted its stake in Versum Materials by 8.5% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,073,306 shares of the basic materials company’s stock valued at $57,472,000 after purchasing an additional 162,893 shares during the period. 83.31% of the stock is owned by institutional investors and hedge funds.

Shares of VSM traded up $0.08 during mid-day trading on Thursday, reaching $51.75. The company had a trading volume of 21,392 shares, compared to its average volume of 1,961,917. Versum Materials Inc has a twelve month low of $25.02 and a twelve month high of $52.58. The company has a current ratio of 5.27, a quick ratio of 4.03 and a debt-to-equity ratio of 3.18. The stock has a market cap of $5.64 billion, a PE ratio of 21.97 and a beta of 2.06.

Versum Materials (NYSE:VSM) last issued its earnings results on Tuesday, May 7th. The basic materials company reported $0.57 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.57. Versum Materials had a return on equity of 109.04% and a net margin of 16.74%. The business had revenue of $326.20 million during the quarter, compared to analysts’ expectations of $340.56 million. During the same period in the prior year, the firm posted $0.59 EPS. Versum Materials’s quarterly revenue was down 4.3% compared to the same quarter last year. On average, sell-side analysts forecast that Versum Materials Inc will post 2.35 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, May 28th. Stockholders of record on Tuesday, May 14th will be issued a $0.08 dividend. The ex-dividend date of this dividend is Monday, May 13th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.62%. Versum Materials’s payout ratio is presently 13.62%.

A number of analysts have commented on VSM shares. Zacks Investment Research downgraded Versum Materials from a “hold” rating to a “sell” rating in a research report on Saturday, January 26th. Loop Capital upgraded Versum Materials from a “hold” rating to a “buy” rating and set a $57.00 price objective for the company in a research report on Tuesday, January 29th. Goldman Sachs Group upgraded Versum Materials from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $26.00 to $31.00 in a research report on Thursday, January 31st. KeyCorp raised their price objective on Versum Materials from $44.00 to $55.00 and gave the stock an “overweight” rating in a research report on Thursday, February 28th. Finally, Credit Suisse Group downgraded Versum Materials from an “outperform” rating to a “neutral” rating in a research report on Thursday, February 28th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $46.60.

COPYRIGHT VIOLATION NOTICE: “Grandview Asset Management LLC Grows Stake in Versum Materials Inc (VSM)” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/4343063/grandview-asset-management-llc-grows-stake-in-versum-materials-inc-vsm.html.

Versum Materials Profile

Versum Materials, Inc develops, manufactures, transports, and handles specialty materials for the semiconductor and display industries in the United States, Taiwan, South Korea, China, Europe, and rest of Asia. The company operates through two segments, Materials, and Delivery Systems and Services (DS&S).

Further Reading: How much can an individual set aside as a catch-up contribution?

Want to see what other hedge funds are holding VSM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Versum Materials Inc (NYSE:VSM).

Institutional Ownership by Quarter for Versum Materials (NYSE:VSM)

Receive News & Ratings for Versum Materials Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versum Materials and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Atara Biotherapeutics  Now Covered by Stifel Nicolaus
Atara Biotherapeutics Now Covered by Stifel Nicolaus
Critical Contrast: MFC Bancorp  and Bancolombia
Critical Contrast: MFC Bancorp and Bancolombia
Paragon Banking Group’s  Hold Rating Reiterated at Numis Securities
Paragon Banking Group’s Hold Rating Reiterated at Numis Securities
Short Interest in Moleculin Biotech Inc  Grows By 327.4%
Short Interest in Moleculin Biotech Inc Grows By 327.4%
OrganiGram  Sets New 52-Week High at $11.30
OrganiGram Sets New 52-Week High at $11.30
Weekly Analysts’ Ratings Changes for Seres Therapeutics
Weekly Analysts’ Ratings Changes for Seres Therapeutics


© 2006-2019 Ticker Report